Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 39

Related Articles by Review for PubMed (Select 18825839)

1.

Stimulant-associated cognitive abnormalities: mechanisms and impact on reward-related behavior and addiction.

Kalechstein AD, Jentsch JD, Kantak KM.

Drug Alcohol Depend. 2008 Oct 1;97(3):276-80. No abstract available.

PMID:
18825839
2.

Understanding drug addiction: a neuropsychological perspective.

Yücel M, Lubman DI, Solowij N, Brewer WJ.

Aust N Z J Psychiatry. 2007 Dec;41(12):957-68. Review.

PMID:
17999268
3.

Clinical implications and methodological challenges in the study of the neuropsychological correlates of cannabis, stimulant, and opioid abuse.

Verdejo-García A, López-Torrecillas F, Giménez CO, Pérez-García M.

Neuropsychol Rev. 2004 Mar;14(1):1-41. Review.

PMID:
15260137
4.

The impact of cigarette smoking on stimulant addiction.

Weinberger AH, Sofuoglu M.

Am J Drug Alcohol Abuse. 2009;35(1):12-7. doi: 10.1080/00952990802326280. Review.

5.

Cannabinoids, opioids and MDMA: neuropsychological interactions related to addiction.

Robledo P.

Curr Drug Targets. 2010 Apr;11(4):429-39. Review.

PMID:
20017726
6.

Preclinical studies on comorbidity between depression and psychostimulant addiction.

Filip M, Frankowska M, Jastrzębska J, Wydra K, Przegaliński E.

Pharmacol Rep. 2013;65(6):1529-34. Review.

7.

Addiction and brain reward and antireward pathways.

Gardner EL.

Adv Psychosom Med. 2011;30:22-60. doi: 10.1159/000324065. Epub 2011 Apr 19. Review.

PMID:
21508625
8.

Role of serotonin 5-HT1B receptors in psychostimulant addiction.

Miszkiel J, Filip M, Przegaliński E.

Pharmacol Rep. 2011;63(6):1310-5. Review.

9.

Antidepressant drug action: a neuropsychological perspective.

Harmer CJ.

Depress Anxiety. 2010 Mar;27(3):231-3. doi: 10.1002/da.20680. Review. No abstract available.

PMID:
20196098
10.

New approach to the neurobiological mechanisms of addiction.

Fürst Z, Riba P, Al-Khrasani M.

Neuropsychopharmacol Hung. 2013 Dec;15(4):189-205. Review.

11.

Stimulant medication for the child with attention-deficit/hyperactivity disorder.

Bennett FC, Brown RT, Craver J, Anderson D.

Pediatr Clin North Am. 1999 Oct;46(5):929-44, vii. Review.

PMID:
10570697
12.

Cognitive dysfunction and chemotherapy: neuropsychological findings in perspective.

Schagen SB, Muller MJ, Boogerd W, Van Dam FS.

Clin Breast Cancer. 2002 Dec;3 Suppl 3:S100-8. Review.

PMID:
12533270
13.

ADHD and substance use disorders: developmental aspects and the impact of stimulant treatment.

Wilson JJ.

Am J Addict. 2007;16 Suppl 1:5-11; quiz 12-3. Review.

PMID:
17453602
14.

Emerging association between addictive gaming and attention-deficit/hyperactivity disorder.

Weinstein A, Weizman A.

Curr Psychiatry Rep. 2012 Oct;14(5):590-7. doi: 10.1007/s11920-012-0311-x. Review.

PMID:
22843540
15.

The role of cognitive control in cocaine dependence.

Garavan H, Hester R.

Neuropsychol Rev. 2007 Sep;17(3):337-45. Epub 2007 Aug 7. Review.

PMID:
17680368
16.

Cognitive impairment in substance abuse.

Vik PW, Cellucci T, Jarchow A, Hedt J.

Psychiatr Clin North Am. 2004 Mar;27(1):97-109, ix. Review.

PMID:
15062633
17.

Comparative neuroscience of stimulant-induced memory dysfunction: role for neurogenesis in the adult hippocampus.

Canales JJ.

Behav Pharmacol. 2010 Sep;21(5-6):379-93. doi: 10.1097/FBP.0b013e32833e16b6. Review.

PMID:
20700045
18.

Cognitive enhancement as a pharmacotherapy target for stimulant addiction.

Sofuoglu M.

Addiction. 2010 Jan;105(1):38-48. doi: 10.1111/j.1360-0443.2009.02791.x. Review.

19.

Addictiveness of central stimulants.

Dackis CA, Gold MS.

Adv Alcohol Subst Abuse. 1990;9(1-2):9-26. Review.

PMID:
1974121
20.

Mechanisms involved in the neurotoxic, cognitive, and neurobehavioral effects of alcohol consumption during adolescence.

Guerri C, Pascual M.

Alcohol. 2010 Feb;44(1):15-26. doi: 10.1016/j.alcohol.2009.10.003. Review.

PMID:
20113871
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk